Abstract
The discovery and isolation of bioactive compounds from medicinal plants opened a new avenue in pharmacology, opening new avenues for cancer treatment. Most of these bioactive compounds are known to affect the hallmarks of cancer such as unrestrained proliferation. This study aims to assess the effect of crude leaf extracts (methanolic, aqueous, ethyl acetate and hexane extracts) from Artocarpus blancoi, locally known as “Antipolo,” on cancer cell proliferation. The MCF-7 cell line was used to screen Antipolo’s cytotoxic activity. However, although MCF-7 is widely used for breast cancer research, it has limitations because it lacks certain mutations found in more aggressive breast cancer subtypes. Crude leaf extracts of A. blancoi were tested for effects on MCF-7 cell viability using an MTT assay and Ki67 immunofluorescence. Phytochemical analysis identified alkaloids, anthraquinones, flavonoids, steroids, and tannins in the leaves of A. blancoi. The ethyl acetate extract was the most cytotoxic (IC50 = 47.2 μg/mL). Immunofluorescence staining for Ki67 showed that Ki67 expression decreased at lower concentrations (25 and 12.5 μg/mL) of the ethyl acetate extract. Altogether, these results suggest that the ethyl acetate extract from A. blancoi may possess potential as a therapeutic agent in breast cancer treatment.